Effect of a Dietary Supplement on Weight Loss and Psychological Wellbeing in Overweight Individuals
NCT ID: NCT05758363
Last Updated: 2024-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-03-09
2023-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Natural Ingredient on Obesity
NCT04105192
Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults
NCT05333315
To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects
NCT04506749
A Clinical Study to Evaluate the Efficacy of Dietary Supplement to Alleviate Stress Versus Placebo in Subjects with Mild to Moderate Levels of Stress
NCT06672965
Effectiveness of a Natural Ingredient on Appetite Regulation
NCT04345029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects will be randomized to each of the study arms (consumption of the experimental product or control product).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group
Consumption of dietary supplement capsules for 6 months.
Consumption of dietary supplement.
Consumption of a dietary supplement rich in glutathione, selenium, zinc, vitamin D and EPA/DHA. 1 capsule per day of the dietary supplement with breakfast.
Control Group
Identically appearing placebo capsules consumed for 6 months.
Consumption of control product
Consumption of 1 capsule per day of control product of identical appearance with breakfast.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Consumption of dietary supplement.
Consumption of a dietary supplement rich in glutathione, selenium, zinc, vitamin D and EPA/DHA. 1 capsule per day of the dietary supplement with breakfast.
Consumption of control product
Consumption of 1 capsule per day of control product of identical appearance with breakfast.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI over 25 kg/m2.
* Subjects who are smokers or non-smokers, but in any case who do not modify their nicotinic habits during their participation in the study.
Exclusion Criteria
* BMI less than 25 Kg/m2.
* History of allergic hypersensitivity or poor tolerance to any component of the products under study.
* Participation in another clinical trial in the three months prior to the study.
* Unwillingness or inability to comply with clinical trial procedures.
* Pregnant woman.
* Participants with an active daily exercise activity.
* Subjects whose condition makes them ineligible for the study at the investigator's discretion.
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Católica San Antonio de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Desirée Victoria Montesinos
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCAM San Antonio Catholic University of Murcia
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE012309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.